BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5626106)

  • 1. [Fluctuations of the long-acting thyroid stimulator (LATS) concentration in the blood and its significance in hyperthyroidism].
    Noguchi A; Kurihara H; Ozeki Y; Sato S
    Nihon Rinsho; 1967 Oct; 25(8):1723-32. PubMed ID: 5626106
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA; Gordin A
    Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract]   [Full Text] [Related]  

  • 3. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
    zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
    Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pitfalls in the biological demonstration of the "long acting thyroid stimulator" (LATS)].
    Mertz DP; Stelzer M
    Schweiz Med Wochenschr; 1968 Sep; 98(38):1471-5. PubMed ID: 5680881
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical significance of LATS and TSH in the blood.
    Lemarchand-Béraud T; Griessen M; Scazziga BR
    Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
    Friis T
    Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
    [No Abstract]   [Full Text] [Related]  

  • 7. The pathogenesis of thyrotoxicosis the discovery of LATS.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma thyrotropin (TSH) and long-acting thyroid stimulator (LATS) in patients treated for thyroid carcinoma.
    Valenta L; Lemarchand-Béraud T; Vannotti A
    Eur J Cancer (1965); 1970 Apr; 6(2):139-43. PubMed ID: 5450187
    [No Abstract]   [Full Text] [Related]  

  • 9. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
    Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
    J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
    [No Abstract]   [Full Text] [Related]  

  • 10. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
    Busnardo B; Accordi F; Debiasi S
    Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
    [No Abstract]   [Full Text] [Related]  

  • 11. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
    Gautier E; Juillard E; Lemarchand-Béraud T
    Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
    [No Abstract]   [Full Text] [Related]  

  • 12. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
    [No Abstract]   [Full Text] [Related]  

  • 13. [Long-acting thyroid stimulator (LATS) as the cause of hyperthyroidism. Comparison of different TSH and LATS preparations].
    Seif F
    Dtsch Med Wochenschr; 1967 Jan; 92(4):147-52. PubMed ID: 6016320
    [No Abstract]   [Full Text] [Related]  

  • 14. [LATS and thyroid antibody level in the blood in Basedow's disease].
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Orv Hetil; 1968 Aug; 109(33):1799-804. PubMed ID: 5714825
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of thyrotropic hormone and long acting thyroid stimulator by the McKenzie technique. Critical study of the method].
    Bonnyns M
    Rev Fr Etud Clin Biol; 1968 Nov; 13(9):845-52. PubMed ID: 5709509
    [No Abstract]   [Full Text] [Related]  

  • 16. [Significance of the "long acting thyroid stimulator"].
    Tourneur R; Letonturier P; Sénécal P
    Cah Med; 1974 Mar; 15(3):121-3. PubMed ID: 4479615
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long-acting thyroid stimulator (LATS) in thyroid pathology].
    Winand R
    Rev Med Liege; 1970 Aug; 25(15):478-82. PubMed ID: 5468466
    [No Abstract]   [Full Text] [Related]  

  • 18. The interaction between LATS and thyroid tissue in vitro.
    Smith BR; Munro DS
    Clin Sci; 1969 Oct; 37(2):566. PubMed ID: 5359011
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum thyrotropic hormone (T.S.H.) and the long acting stimulator substance (L.A.T.S.) in hyperthyroidism. Preliminary communication].
    Bonnyns M
    Rev Fr Etud Clin Biol; 1967 Jan; 12(1):77-9. PubMed ID: 6052803
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
    Lepp A; Oliner L
    Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.